This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Labels on alcohol could soon feature more thorough information on allergens and nutritional value, if a set of new proposals from the U.S. Treasury Department is approved. On Friday the Alcohol and Tobacco Tax and Trade Bureau, or TTB, published a couple of proposed rules: One that would add an “Alcohol Facts” box — akin to “Nutrition Facts” on food products — to drinks, and another would require companies to disclose if alcohol contains any major
Fresh concerns have been raised around the 'serious, unintended consequences' that ongoing pharmacy closures could have on patients following new analysis on the situation. The National Pharmacy Association (NPA) has today revealed 222 pharmacies closed permanently in 2024 the second highest annual closure rate on record and second only to the previous year.
SAN FRANCISCO — The J.P. Morgan Healthcare Conference isn’t just a venue for companies in the industry to outline their plans for the year or tamp down questions about their finances. The week is also a time for many venture capitalists to meet with startups or other investors to make plans for the year. So, what are their plans for new investments?
There was a 'missed opportunity' to make use of the community pharmacy sector during the early stages of the Covid-19 vaccination programme roll-out, an inquiry has been told. Speaking on behalf of the National Pharmacy Association, lawyer Deirdre Domingo also asked the UK Covid-19 Inquiry to consider whether there was 'a broader tendency' to overlook […] The post Covid inquiry: 'Missed opportunity' to utilise pharmacies in vaccine roll-out appeared first on The Pharmacist.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
Johnson & Johnson (J&J) recently announced the acquisition of Intra-Cellular Therapies, a biopharmaceutical company specialising in the development of treatments targeting complex psychiatric and neurological disorders. The deal is the biggest biotech M&A transaction since 2023. As part of the acquisition, J&J will obtain Intra-Cellulars extensive neurology portfolio, which will allow them to grow its market share in major indications such as schizophrenia, agitation and psychosi
Johnson & Johnson (J&J) recently announced the acquisition of Intra-Cellular Therapies, a biopharmaceutical company specialising in the development of treatments targeting complex psychiatric and neurological disorders. The deal is the biggest biotech M&A transaction since 2023. As part of the acquisition, J&J will obtain Intra-Cellulars extensive neurology portfolio, which will allow them to grow its market share in major indications such as schizophrenia, agitation and psychosi
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hey! This is Meghana. Hope those of you who were in San Francisco for J.P. Morgan are resting, recovering, and not coping with any quad-emic strains. Today, we see insulin-producing cells survive in a human body without triggering an immune rejection, and have some big news from CMS.
To start, can you tell us about Lonza Capsules & Health Ingredients and its presence in the APAC market? With roots back to Capsugel and InterHealth, Lonza has been a manufacturing pioneer and trusted partner for leading global pharmaceutical and nutraceutical companies for more than 100 years. This experience and expertise has allowed us to become an industry leader in providing innovative and reliable capsules and science-backed ingredients for use in a variety of pharma and nutra applicat
As environmental concerns continue to intensify, the pressure on the pharmaceutical industry to reduce its overall environmental impact, particularly in final dosage forms, is growing proportionately. With over 600 billion pharmaceutical capsules consumed annually worldwide, Lonza (the largest global supplier to the pharma industry) recognises its crucial role in driving sustainable practices.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the different forms as a single product.
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer. The studies - both conducted in patient samples and animal models - found that inhibiting a protein called RSK1 reduces inflammation and stops the progression of blood cancers called myeloproliferative neoplasms (MPNs) as well as an aggressive form of acut
Pharmaceutical Technology spoke with Charles Ruban, president and CEO, Verdot, about the focus of moving to sustainability practices in pharmaceutical manufacturing.
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Donald Prentiss, founder and CEO, Qualthera, describes compounding pharmacies efforts in tackling the tirzepatide shortage, and dispels the notion that commercialized and compounded drugs are competing with one another.
A high-dose form of Novo’s obesity drug led to 20% weight loss over 72 weeks. Meanwhile, Atara got a complete response letter and Boehringer reported a Phase 3 failure.
The Lonza CEO said the company is not under any pressure to exit the Capsules and Health Ingredients (CHI) business and is expecting strong interest for it.
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
315 
Let's personalize your content